APO Research
Talk to an analyst

APO RESEARCH · REPORT

Hyperimmune Globulin Injection

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Hyperimmune Globulin Injection Market Analysis and Forecast 2026-2032

21 December 2025199 pages

Choose your research edition.

Industry ResearchHyperimmune Globulin Injection Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Hyperimmune Globulin Injection Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Hyperimmune Globulin Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hyperimmune Globulin Injection Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Hyperimmune Globulin Injection Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Hyperimmune Globulin Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Hyperimmune Globulin Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Hyperimmune Globulin Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Hyperimmune Globulin Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Hyperimmune Globulin Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Hyperimmune Globulin Injection include CNBG, Sichuan Yuanda Shuyang, Shanghai RAAS, Hualan Bio, CBPO, Kedrion, Kamada, Grifols and Emergent, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Hyperimmune Globulin Injection, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Hyperimmune Globulin Injection, also provides the sales of main regions and countries. Of the upcoming market potential for Hyperimmune Globulin Injection, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Hyperimmune Globulin Injection sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Hyperimmune Globulin Injection market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Hyperimmune Globulin Injection sales, projected growth trends, production technology, application and end-user industry.

Hyperimmune Globulin Injection Segment by Company

CNBG

Sichuan Yuanda Shuyang

Shanghai RAAS

Hualan Bio

CBPO

Kedrion

Kamada

Grifols

Emergent

CSL Behring

Biotest

ADMA Biologics

Hyperimmune Globulin Injection Segment by Type

Hepatitis B Immuneglobulins

Tetanus Toxin Immuneglobulins

Rabies Immuneglobulins

Rho(D) Immune Globulin

Cytomegalovirus Immune Globulin

Varicella-Zoster Immune Globulin

Others

Hyperimmune Globulin Injection Segment by Application

Government Institution

Private Sector

Others

Hyperimmune Globulin Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hyperimmune Globulin Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hyperimmune Globulin Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hyperimmune Globulin Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Hyperimmune Globulin Injection in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Hyperimmune Globulin Injection manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Hyperimmune Globulin Injection sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Hyperimmune Globulin Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Hepatitis B Immuneglobulins Major Manufacturers Table 3. Tetanus Toxin Immuneglobulins Major Manufacturers Table 4. Rabies Immuneglobulins Major Manufacturers Table 5. Rho(D) Immune Globulin Major Manufacturers Table 6. Cytomegalovirus Immune Globulin Major Manufacturers Table 7. Varicella-Zoster Immune Globulin Major Manufacturers Table 8. Others Major Manufacturers Table 9. Global Hyperimmune Globulin Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 10. Government Institution Major Manufacturers Table 11. Private Sector Major Manufacturers Table 12. Others Major Manufacturers Table 13. Hyperimmune Globulin Injection Industry Trends Table 14. Hyperimmune Globulin Injection Industry Drivers Table 15. Hyperimmune Globulin Injection Industry Opportunities and Challenges Table 16. Hyperimmune Globulin Injection Industry Restraints Table 17. Global Hyperimmune Globulin Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Hyperimmune Globulin Injection Revenue by Region (2021-2026) & (US$ Million) Table 19. Global Hyperimmune Globulin Injection Revenue by Region (2027-2032) & (US$ Million) Table 20. Global Hyperimmune Globulin Injection Revenue Market Share by Region (2021-2026) Table 21. Global Hyperimmune Globulin Injection Revenue Market Share by Region (2027-2032) Table 22. Global Hyperimmune Globulin Injection Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 23. Global Hyperimmune Globulin Injection Sales by Region (2021-2026) & (k units) Table 24. Global Hyperimmune Globulin Injection Sales by Region (2027-2032) & (k units) Table 25. Global Hyperimmune Globulin Injection Sales Market Share by Region (2021-2026) Table 26. Global Hyperimmune Globulin Injection Sales Market Share by Region (2027-2032) Table 27. Global Hyperimmune Globulin Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Hyperimmune Globulin Injection Revenue Market Share by Manufacturers (2021-2026) Table 29. Global Hyperimmune Globulin Injection Sales by Manufacturers (US$ Million) & (2021-2026) Table 30. Global Hyperimmune Globulin Injection Sales Market Share by Manufacturers (2021-2026) Table 31. Global Hyperimmune Globulin Injection Sales Price (US$/unit) of Manufacturers (2021-2026) Table 32. Global Hyperimmune Globulin Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 33. Global Hyperimmune Globulin Injection Key Manufacturers Manufacturing Sites & Headquarters Table 34. Global Hyperimmune Globulin Injection Manufacturers, Product Type & Application Table 35. Global Hyperimmune Globulin Injection Manufacturers' Establishment Date Table 36. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 37. Global Hyperimmune Globulin Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 38. Global Hyperimmune Globulin Injection Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Hyperimmune Globulin Injection Revenue by Type (2021-2026) & (US$ Million) Table 40. Global Hyperimmune Globulin Injection Revenue by Type (2027-2032) & (US$ Million) Table 41. Global Hyperimmune Globulin Injection Revenue Market Share by Type (2021-2026) Table 42. Global Hyperimmune Globulin Injection Revenue Market Share by Type (2027-2032) Table 43. Global Hyperimmune Globulin Injection Sales by Type 2021 VS 2025 VS 2032 (k units) Table 44. Global Hyperimmune Globulin Injection Sales by Type (2021-2026) & (k units) Table 45. Global Hyperimmune Globulin Injection Sales by Type (2027-2032) & (k units) Table 46. Global Hyperimmune Globulin Injection Sales Market Share by Type (2021-2026) Table 47. Global Hyperimmune Globulin Injection Sales Market Share by Type (2027-2032) Table 48. Global Hyperimmune Globulin Injection Price by Type (2021-2026) & (US$/unit) Table 49. Global Hyperimmune Globulin Injection Price by Type (2027-2032) & (US$/unit) Table 50. Global Hyperimmune Globulin Injection Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Hyperimmune Globulin Injection Revenue by Application (2021-2026) & (US$ Million) Table 52. Global Hyperimmune Globulin Injection Revenue by Application (2027-2032) & (US$ Million) Table 53. Global Hyperimmune Globulin Injection Revenue Market Share by Application (2021-2026) Table 54. Global Hyperimmune Globulin Injection Revenue Market Share by Application (2027-2032) Table 55. Global Hyperimmune Globulin Injection Sales by Application 2021 VS 2025 VS 2032 (k units) Table 56. Global Hyperimmune Globulin Injection Sales by Application (2021-2026) & (k units) Table 57. Global Hyperimmune Globulin Injection Sales by Application (2027-2032) & (k units) Table 58. Global Hyperimmune Globulin Injection Sales Market Share by Application (2021-2026) Table 59. Global Hyperimmune Globulin Injection Sales Market Share by Application (2027-2032) Table 60. Global Hyperimmune Globulin Injection Price by Application (2021-2026) & (US$/unit) Table 61. Global Hyperimmune Globulin Injection Price by Application (2027-2032) & (US$/unit) Table 62. CNBG Company Information Table 63. CNBG Business Overview Table 64. CNBG Hyperimmune Globulin Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 65. CNBG Hyperimmune Globulin Injection Product Portfolio Table 66. CNBG Recent Development Table 67. Sichuan Yuanda Shuyang Company Information Table 68. Sichuan Yuanda Shuyang Business Overview Table 69. Sichuan Yuanda Shuyang Hyperimmune Globulin Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 70. Sichuan Yuanda Shuyang Hyperimmune Globulin Injection Product Portfolio Table 71. Sichuan Yuanda Shuyang Recent Development Table 72. Shanghai RAAS Company Information Table 73. Shanghai RAAS Business Overview Table 74. Shanghai RAAS Hyperimmune Globulin Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. Shanghai RAAS Hyperimmune Globulin Injection Product Portfolio Table 76. Shanghai RAAS Recent Development Table 77. Hualan Bio Company Information Table 78. Hualan Bio Business Overview Table 79. Hualan Bio Hyperimmune Globulin Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. Hualan Bio Hyperimmune Globulin Injection Product Portfolio Table 81. Hualan Bio Recent Development Table 82. CBPO Company Information Table 83. CBPO Business Overview Table 84. CBPO Hyperimmune Globulin Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 85. CBPO Hyperimmune Globulin Injection Product Portfolio Table 86. CBPO Recent Development Table 87. Kedrion Company Information Table 88. Kedrion Business Overview Table 89. Kedrion Hyperimmune Globulin Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 90. Kedrion Hyperimmune Globulin Injection Product Portfolio Table 91. Kedrion Recent Development Table 92. Kamada Company Information Table 93. Kamada Business Overview Table 94. Kamada Hyperimmune Globulin Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 95. Kamada Hyperimmune Globulin Injection Product Portfolio Table 96. Kamada Recent Development Table 97. Grifols Company Information Table 98. Grifols Business Overview Table 99. Grifols Hyperimmune Globulin Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 100. Grifols Hyperimmune Globulin Injection Product Portfolio Table 101. Grifols Recent Development Table 102. Emergent Company Information Table 103. Emergent Business Overview Table 104. Emergent Hyperimmune Globulin Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 105. Emergent Hyperimmune Globulin Injection Product Portfolio Table 106. Emergent Recent Development Table 107. CSL Behring Company Information Table 108. CSL Behring Business Overview Table 109. CSL Behring Hyperimmune Globulin Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 110. CSL Behring Hyperimmune Globulin Injection Product Portfolio Table 111. CSL Behring Recent Development Table 112. Biotest Company Information Table 113. Biotest Business Overview Table 114. Biotest Hyperimmune Globulin Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 115. Biotest Hyperimmune Globulin Injection Product Portfolio Table 116. Biotest Recent Development Table 117. ADMA Biologics Company Information Table 118. ADMA Biologics Business Overview Table 119. ADMA Biologics Hyperimmune Globulin Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 120. ADMA Biologics Hyperimmune Globulin Injection Product Portfolio Table 121. ADMA Biologics Recent Development Table 122. North America Hyperimmune Globulin Injection Revenue by Type (2021-2026) & (US$ Million) Table 123. North America Hyperimmune Globulin Injection Revenue by Type (2027-2032) & (US$ Million) Table 124. North America Hyperimmune Globulin Injection Sales by Type (2021-2026) & (k units) Table 125. North America Hyperimmune Globulin Injection Sales by Type (2027-2032) & (k units) Table 126. North America Hyperimmune Globulin Injection Sales Price by Type (2021-2026) & (US$/unit) Table 127. North America Hyperimmune Globulin Injection Sales Price by Type (2027-2032) & (US$/unit) Table 128. North America Hyperimmune Globulin Injection Revenue by Application (2021-2026) & (US$ Million) Table 129. North America Hyperimmune Globulin Injection Revenue by Application (2027-2032) & (US$ Million) Table 130. North America Hyperimmune Globulin Injection Sales by Application (2021-2026) & (k units) Table 131. North America Hyperimmune Globulin Injection Sales by Application (2027-2032) & (k units) Table 132. North America Hyperimmune Globulin Injection Sales Price by Application (2021-2026) & (US$/unit) Table 133. North America Hyperimmune Globulin Injection Sales Price by Application (2027-2032) & (US$/unit) Table 134. North America Hyperimmune Globulin Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 135. North America Hyperimmune Globulin Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 136. North America Hyperimmune Globulin Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 137. North America Hyperimmune Globulin Injection Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 138. North America Hyperimmune Globulin Injection Sales by Country (2021-2026) & (k units) Table 139. North America Hyperimmune Globulin Injection Sales by Country (2027-2032) & (k units) Table 140. North America Hyperimmune Globulin Injection Sales Price by Country (2021-2026) & (US$/unit) Table 141. North America Hyperimmune Globulin Injection Sales Price by Country (2027-2032) & (US$/unit) Table 142. United States Hyperimmune Globulin Injection Revenue (2021-2032) & (US$ Million) Table 143. Canada Hyperimmune Globulin Injection Revenue (2021-2032) & (US$ Million) Table 144. Mexico Hyperimmune Globulin Injection Revenue (2021-2032) & (US$ Million) Table 145. Europe Hyperimmune Globulin Injection Revenue by Type (2021-2026) & (US$ Million) Table 146. Europe Hyperimmune Globulin Injection Revenue by Type (2027-2032) & (US$ Million) Table 147. Europe Hyperimmune Globulin Injection Sales by Type (2021-2026) & (k units) Table 148. Europe Hyperimmune Globulin Injection Sales by Type (2027-2032) & (k units) Table 149. Europe Hyperimmune Globulin Injection Sales Price by Type (2021-2026) & (US$/unit) Table 150. Europe Hyperimmune Globulin Injection Sales Price by Type (2027-2032) & (US$/unit) Table 151. Europe Hyperimmune Globulin Injection Revenue by Application (2021-2026) & (US$ Million) Table 152. Europe Hyperimmune Globulin Injection Revenue by Application (2027-2032) & (US$ Million) Table 153. Europe Hyperimmune Globulin Injection Sales by Application (2021-2026) & (k units) Table 154. Europe Hyperimmune Globulin Injection Sales by Application (2027-2032) & (k units) Table 155. Europe Hyperimmune Globulin Injection Sales Price by Application (2021-2026) & (US$/unit) Table 156. Europe Hyperimmune Globulin Injection Sales Price by Application (2027-2032) & (US$/unit) Table 157. Europe Hyperimmune Globulin Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 158. Europe Hyperimmune Globulin Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 159. Europe Hyperimmune Globulin Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 160. Europe Hyperimmune Globulin Injection Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 161. Europe Hyperimmune Globulin Injection Sales by Country (2021-2026) & (k units) Table 162. Europe Hyperimmune Globulin Injection Sales by Country (2027-2032) & (k units) Table 163. Europe Hyperimmune Globulin Injection Sales Price by Country (2021-2026) & (US$/unit) Table 164. Europe Hyperimmune Globulin Injection Sales Price by Country (2027-2032) & (US$/unit) Table 165. Germany Hyperimmune Globulin Injection Revenue (2021-2032) & (US$ Million) Table 166. France Hyperimmune Globulin Injection Revenue (2021-2032) & (US$ Million) Table 167. U.K. Hyperimmune Globulin Injection Revenue (2021-2032) & (US$ Million) Table 168. Italy Hyperimmune Globulin Injection Revenue (2021-2032) & (US$ Million) Table 169. Russia Hyperimmune Globulin Injection Revenue (2021-2032) & (US$ Million) Table 170. Spain Hyperimmune Globulin Injection Revenue (2021-2032) & (US$ Million) Table 171. Netherlands Hyperimmune Globulin Injection Revenue (2021-2032) & (US$ Million) Table 172. Switzerland Hyperimmune Globulin Injection Revenue (2021-2032) & (US$ Million) Table 173. Sweden Hyperimmune Globulin Injection Revenue (2021-2032) & (US$ Million) Table 174. Poland Hyperimmune Globulin Injection Revenue (2021-2032) & (US$ Million) Table 175. China Hyperimmune Globulin Injection Revenue by Type (2021-2026) & (US$ Million) Table 176. China Hyperimmune Globulin Injection Revenue by Type (2027-2032) & (US$ Million) Table 177. China Hyperimmune Globulin Injection Sales by Type (2021-2026) & (k units) Table 178. China Hyperimmune Globulin Injection Sales by Type (2027-2032) & (k units) Table 179. China Hyperimmune Globulin Injection Sales Price by Type (2021-2026) & (US$/unit) Table 180. China Hyperimmune Globulin Injection Sales Price by Type (2027-2032) & (US$/unit) Table 181. China Hyperimmune Globulin Injection Revenue by Application (2021-2026) & (US$ Million) Table 182. China Hyperimmune Globulin Injection Revenue by Application (2027-2032) & (US$ Million) Table 183. China Hyperimmune Globulin Injection Sales by Application (2021-2026) & (k units) Table 184. China Hyperimmune Globulin Injection Sales by Application (2027-2032) & (k units) Table 185. China Hyperimmune Globulin Injection Sales Price by Application (2021-2026) & (US$/unit) Table 186. China Hyperimmune Globulin Injection Sales Price by Application (2027-2032) & (US$/unit) Table 187. Asia Hyperimmune Globulin Injection Revenue by Type (2021-2026) & (US$ Million) Table 188. Asia Hyperimmune Globulin Injection Revenue by Type (2027-2032) & (US$ Million) Table 189. Asia Hyperimmune Globulin Injection Sales by Type (2021-2026) & (k units) Table 190. Asia Hyperimmune Globulin Injection Sales by Type (2027-2032) & (k units) Table 191. Asia Hyperimmune Globulin Injection Sales Price by Type (2021-2026) & (US$/unit) Table 192. Asia Hyperimmune Globulin Injection Sales Price by Type (2027-2032) & (US$/unit) Table 193. Asia Hyperimmune Globulin Injection Revenue by Application (2021-2026) & (US$ Million) Table 194. Asia Hyperimmune Globulin Injection Revenue by Application (2027-2032) & (US$ Million) Table 195. Asia Hyperimmune Globulin Injection Sales by Application (2021-2026) & (k units) Table 196. Asia Hyperimmune Globulin Injection Sales by Application (2027-2032) & (k units) Table 197. Asia Hyperimmune Globulin Injection Sales Price by Application (2021-2026) & (US$/unit) Table 198. Asia Hyperimmune Globulin Injection Sales Price by Application (2027-2032) & (US$/unit) Table 199. Asia Hyperimmune Globulin Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 200. Asia Hyperimmune Globulin Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 201. Asia Hyperimmune Globulin Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 202. Asia Hyperimmune Globulin Injection Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 203. Asia Hyperimmune Globulin Injection Sales by Country (2021-2026) & (k units) Table 204. Asia Hyperimmune Globulin Injection Sales by Country (2027-2032) & (k units) Table 205. Asia Hyperimmune Globulin Injection Sales Price by Country (2021-2026) & (US$/unit) Table 206. Asia Hyperimmune Globulin Injection Sales Price by Country (2027-2032) & (US$/unit) Table 207. Japan Hyperimmune Globulin Injection Revenue (2021-2032) & (US$ Million) Table 208. South Korea Hyperimmune Globulin Injection Revenue (2021-2032) & (US$ Million) Table 209. India Hyperimmune Globulin Injection Revenue (2021-2032) & (US$ Million) Table 210. Australia Hyperimmune Globulin Injection Revenue (2021-2032) & (US$ Million) Table 211. Taiwan Hyperimmune Globulin Injection Revenue (2021-2032) & (US$ Million) Table 212. Southeast Asia Hyperimmune Globulin Injection Revenue (2021-2032) & (US$ Million) Table 213. SAMEA Hyperimmune Globulin Injection Revenue by Type (2021-2026) & (US$ Million) Table 214. SAMEA Hyperimmune Globulin Injection Revenue by Type (2027-2032) & (US$ Million) Table 215. SAMEA Hyperimmune Globulin Injection Sales by Type (2021-2026) & (k units) Table 216. SAMEA Hyperimmune Globulin Injection Sales by Type (2027-2032) & (k units) Table 217. SAMEA Hyperimmune Globulin Injection Sales Price by Type (2021-2026) & (US$/unit) Table 218. SAMEA Hyperimmune Globulin Injection Sales Price by Type (2027-2032) & (US$/unit) Table 219. SAMEA Hyperimmune Globulin Injection Revenue by Application (2021-2026) & (US$ Million) Table 220. SAMEA Hyperimmune Globulin Injection Revenue by Application (2027-2032) & (US$ Million) Table 221. SAMEA Hyperimmune Globulin Injection Sales by Application (2021-2026) & (k units) Table 222. SAMEA Hyperimmune Globulin Injection Sales by Application (2027-2032) & (k units) Table 223. SAMEA Hyperimmune Globulin Injection Sales Price by Application (2021-2026) & (US$/unit) Table 224. SAMEA Hyperimmune Globulin Injection Sales Price by Application (2027-2032) & (US$/unit) Table 225. SAMEA Hyperimmune Globulin Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 226. SAMEA Hyperimmune Globulin Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 227. SAMEA Hyperimmune Globulin Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 228. SAMEA Hyperimmune Globulin Injection Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 229. SAMEA Hyperimmune Globulin Injection Sales by Country (2021-2026) & (k units) Table 230. SAMEA Hyperimmune Globulin Injection Sales by Country (2027-2032) & (k units) Table 231. SAMEA Hyperimmune Globulin Injection Sales Price by Country (2021-2026) & (US$/unit) Table 232. SAMEA Hyperimmune Globulin Injection Sales Price by Country (2027-2032) & (US$/unit) Table 233. Brazil Hyperimmune Globulin Injection Revenue (2021-2032) & (US$ Million) Table 234. Argentina Hyperimmune Globulin Injection Revenue (2021-2032) & (US$ Million) Table 235. Chile Hyperimmune Globulin Injection Revenue (2021-2032) & (US$ Million) Table 236. Colombia Hyperimmune Globulin Injection Revenue (2021-2032) & (US$ Million) Table 237. Peru Hyperimmune Globulin Injection Revenue (2021-2032) & (US$ Million) Table 238. Saudi Arabia Hyperimmune Globulin Injection Revenue (2021-2032) & (US$ Million) Table 239. Israel Hyperimmune Globulin Injection Revenue (2021-2032) & (US$ Million) Table 240. UAE Hyperimmune Globulin Injection Revenue (2021-2032) & (US$ Million) Table 241. Turkey Hyperimmune Globulin Injection Revenue (2021-2032) & (US$ Million) Table 242. Iran Hyperimmune Globulin Injection Revenue (2021-2032) & (US$ Million) Table 243. Egypt Hyperimmune Globulin Injection Revenue (2021-2032) & (US$ Million) Table 244. Key Raw Materials Table 245. Raw Materials Key Suppliers Table 246. Hyperimmune Globulin Injection Distributors List Table 247. Hyperimmune Globulin Injection Customers List Table 248. Research Programs/Design for This Report Table 249. Authors List of This Report Table 250. Secondary Sources Table 251. Primary Sources List of Figures Figure 1. Hyperimmune Globulin Injection Image Figure 2. Global Hyperimmune Globulin Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Hyperimmune Globulin Injection Market Size Share 2021 VS 2025 VS 2032 Figure 4. Hepatitis B Immuneglobulins Image Figure 5. Tetanus Toxin Immuneglobulins Image Figure 6. Rabies Immuneglobulins Image Figure 7. Rho(D) Immune Globulin Image Figure 8. Cytomegalovirus Immune Globulin Image Figure 9. Varicella-Zoster Immune Globulin Image Figure 10. Others Image Figure 11. Global Hyperimmune Globulin Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Hyperimmune Globulin Injection Market Size Share 2021 VS 2025 VS 2032 Figure 13. Government Institution Image Figure 14. Private Sector Image Figure 15. Others Image Figure 16. Global Hyperimmune Globulin Injection Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Hyperimmune Globulin Injection Revenue (2021-2032) & (US$ Million) Figure 18. Global Hyperimmune Globulin Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Hyperimmune Globulin Injection Revenue Market Share by Region: 2025 Versus 2032 Figure 20. Global Hyperimmune Globulin Injection Revenue Market Share by Region (2021-2032) Figure 21. Global Hyperimmune Globulin Injection Sales (2021-2032) & (k units) Figure 22. Global Hyperimmune Globulin Injection Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 23. Global Hyperimmune Globulin Injection Sales Market Share by Region (2021-2032) Figure 24. US & Canada & Mexico Hyperimmune Globulin Injection Sales YoY (2021-2032) & (k units) Figure 25. Europe Hyperimmune Globulin Injection Sales YoY (2021-2032) & (k units) Figure 26. China Hyperimmune Globulin Injection Sales YoY (2021-2032) & (k units) Figure 27. Asia (Excluding China) Hyperimmune Globulin Injection Sales YoY (2021-2032) & (k units) Figure 28. South America, Middle East and Africa Hyperimmune Globulin Injection Sales YoY (2021-2032) & (k units) Figure 29. Global Hyperimmune Globulin Injection Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 30. Global Hyperimmune Globulin Injection Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 31. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 32. Global Hyperimmune Globulin Injection Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Hyperimmune Globulin Injection Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Hyperimmune Globulin Injection Revenue Market Share by Type (2021-2032) Figure 35. Global Hyperimmune Globulin Injection Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 36. Global Hyperimmune Globulin Injection Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 37. Global Hyperimmune Globulin Injection Sales Market Share by Type (2021-2032) Figure 38. Global Hyperimmune Globulin Injection Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 39. Global Hyperimmune Globulin Injection Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Hyperimmune Globulin Injection Revenue Market Share by Application (2021-2032) Figure 41. Global Hyperimmune Globulin Injection Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 42. Global Hyperimmune Globulin Injection Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 43. Global Hyperimmune Globulin Injection Sales Market Share by Application (2021-2032) Figure 44. North America Hyperimmune Globulin Injection Revenue Share by Type (2021-2032) Figure 45. North America Hyperimmune Globulin Injection Sales Share by Type (2021-2032) Figure 46. North America Hyperimmune Globulin Injection Revenue Share by Application (2021-2032) Figure 47. North America Hyperimmune Globulin Injection Sales Share by Application (2021-2032) Figure 48. North America Hyperimmune Globulin Injection Revenue Share by Country (2021-2032) Figure 49. North America Hyperimmune Globulin Injection Sales Share by Country (2021-2032) Figure 50. Europe Hyperimmune Globulin Injection Revenue Share by Type (2021-2032) Figure 51. Europe Hyperimmune Globulin Injection Sales Share by Type (2021-2032) Figure 52. Europe Hyperimmune Globulin Injection Revenue Share by Application (2021-2032) Figure 53. Europe Hyperimmune Globulin Injection Sales Share by Application (2021-2032) Figure 54. Europe Hyperimmune Globulin Injection Revenue Share by Country (2021-2032) Figure 55. Europe Hyperimmune Globulin Injection Sales Share by Country (2021-2032) Figure 56. China Hyperimmune Globulin Injection Revenue Share by Type (2021-2032) Figure 57. China Hyperimmune Globulin Injection Sales Share by Type (2021-2032) Figure 58. China Hyperimmune Globulin Injection Revenue Share by Application (2021-2032) Figure 59. China Hyperimmune Globulin Injection Sales Share by Application (2021-2032) Figure 60. Asia Hyperimmune Globulin Injection Revenue Share by Type (2021-2032) Figure 61. Asia Hyperimmune Globulin Injection Sales Share by Type (2021-2032) Figure 62. Asia Hyperimmune Globulin Injection Revenue Share by Application (2021-2032) Figure 63. Asia Hyperimmune Globulin Injection Sales Share by Application (2021-2032) Figure 64. Asia Hyperimmune Globulin Injection Revenue Share by Country (2021-2032) Figure 65. Asia Hyperimmune Globulin Injection Sales Share by Country (2021-2032) Figure 66. SAMEA Hyperimmune Globulin Injection Revenue Share by Type (2021-2032) Figure 67. SAMEA Hyperimmune Globulin Injection Sales Share by Type (2021-2032) Figure 68. SAMEA Hyperimmune Globulin Injection Revenue Share by Application (2021-2032) Figure 69. SAMEA Hyperimmune Globulin Injection Sales Share by Application (2021-2032) Figure 70. SAMEA Hyperimmune Globulin Injection Revenue Share by Country (2021-2032) Figure 71. SAMEA Hyperimmune Globulin Injection Sales Share by Country (2021-2032) Figure 72. Hyperimmune Globulin Injection Value Chain Figure 73. Manufacturing Cost Structure Figure 74. Hyperimmune Globulin Injection Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • Hepatitis B Immuneglobulins
  • Tetanus Toxin Immuneglobulins
  • Rabies Immuneglobulins
  • Rho(D) Immune Globulin
  • Cytomegalovirus Immune Globulin
  • Varicella-Zoster Immune Globulin
  • Others
Applications
  • Government Institution
  • Private Sector
  • Others
Companies covered
  • CNBG
  • Sichuan Yuanda Shuyang
  • Shanghai RAAS
  • Hualan Bio
  • CBPO
  • Kedrion
  • Kamada
  • Grifols
  • Emergent
  • CSL Behring
  • Biotest
  • ADMA Biologics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Hyperimmune Globulin Injection Market by Type
  3. 1.2.1 Global Hyperimmune Globulin Injection Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Hepatitis B Immuneglobulins
  5. 1.2.3 Tetanus Toxin Immuneglobulins
  6. 1.2.4 Rabies Immuneglobulins
  7. 1.2.5 Rho(D) Immune Globulin
  8. 1.2.6 Cytomegalovirus Immune Globulin
  9. 1.2.7 Varicella-Zoster Immune Globulin
  10. 1.2.8 Others
  11. 1.3 Hyperimmune Globulin Injection Market by Application
  12. 1.3.1 Global Hyperimmune Globulin Injection Market Size by Application, 2021 VS 2025 VS 2032
  13. 1.3.2 Government Institution
  14. 1.3.3 Private Sector
  15. 1.3.4 Others
  16. 1.4 Assumptions and Limitations
  17. 1.5 Study Goals and Objectives
2 Hyperimmune Globulin Injection Market Dynamics
  1. 2.1 Hyperimmune Globulin Injection Industry Trends
  2. 2.2 Hyperimmune Globulin Injection Industry Drivers
  3. 2.3 Hyperimmune Globulin Injection Industry Opportunities and Challenges
  4. 2.4 Hyperimmune Globulin Injection Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Hyperimmune Globulin Injection Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Hyperimmune Globulin Injection Revenue by Region
  3. 3.2.1 Global Hyperimmune Globulin Injection Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Hyperimmune Globulin Injection Revenue by Region (2021-2026)
  5. 3.2.3 Global Hyperimmune Globulin Injection Revenue by Region (2027-2032)
  6. 3.2.4 Global Hyperimmune Globulin Injection Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Hyperimmune Globulin Injection Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Hyperimmune Globulin Injection Sales by Region
  9. 3.4.1 Global Hyperimmune Globulin Injection Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Hyperimmune Globulin Injection Sales by Region (2021-2026)
  11. 3.4.3 Global Hyperimmune Globulin Injection Sales by Region (2027-2032)
  12. 3.4.4 Global Hyperimmune Globulin Injection Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Hyperimmune Globulin Injection Revenue by Manufacturers
  2. 4.1.1 Global Hyperimmune Globulin Injection Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Hyperimmune Globulin Injection Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Hyperimmune Globulin Injection Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Hyperimmune Globulin Injection Sales by Manufacturers
  6. 4.2.1 Global Hyperimmune Globulin Injection Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Hyperimmune Globulin Injection Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Hyperimmune Globulin Injection Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Hyperimmune Globulin Injection Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Hyperimmune Globulin Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Hyperimmune Globulin Injection Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Hyperimmune Globulin Injection Manufacturers, Product Type & Application
  13. 4.7 Global Hyperimmune Globulin Injection Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Hyperimmune Globulin Injection Market CR5 and HHI
  16. 4.8.2 2025 Hyperimmune Globulin Injection Tier 1, Tier 2, and Tier 3
5 Hyperimmune Globulin Injection Market by Type
  1. 5.1 Global Hyperimmune Globulin Injection Revenue by Type
  2. 5.1.1 Global Hyperimmune Globulin Injection Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Hyperimmune Globulin Injection Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Hyperimmune Globulin Injection Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Hyperimmune Globulin Injection Sales by Type
  6. 5.2.1 Global Hyperimmune Globulin Injection Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Hyperimmune Globulin Injection Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Hyperimmune Globulin Injection Sales Market Share by Type (2021-2032)
  9. 5.3 Global Hyperimmune Globulin Injection Price by Type
6 Hyperimmune Globulin Injection Market by Application
  1. 6.1 Global Hyperimmune Globulin Injection Revenue by Application
  2. 6.1.1 Global Hyperimmune Globulin Injection Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Hyperimmune Globulin Injection Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Hyperimmune Globulin Injection Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Hyperimmune Globulin Injection Sales by Application
  6. 6.2.1 Global Hyperimmune Globulin Injection Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Hyperimmune Globulin Injection Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Hyperimmune Globulin Injection Sales Market Share by Application (2021-2032)
  9. 6.3 Global Hyperimmune Globulin Injection Price by Application
7 Company Profiles
  1. 7.1 CNBG
  2. 7.1.1 CNBG Company Information
  3. 7.1.2 CNBG Business Overview
  4. 7.1.3 CNBG Hyperimmune Globulin Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 CNBG Hyperimmune Globulin Injection Product Portfolio
  6. 7.1.5 CNBG Recent Developments
  7. 7.2 Sichuan Yuanda Shuyang
  8. 7.2.1 Sichuan Yuanda Shuyang Company Information
  9. 7.2.2 Sichuan Yuanda Shuyang Business Overview
  10. 7.2.3 Sichuan Yuanda Shuyang Hyperimmune Globulin Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Sichuan Yuanda Shuyang Hyperimmune Globulin Injection Product Portfolio
  12. 7.2.5 Sichuan Yuanda Shuyang Recent Developments
  13. 7.3 Shanghai RAAS
  14. 7.3.1 Shanghai RAAS Company Information
  15. 7.3.2 Shanghai RAAS Business Overview
  16. 7.3.3 Shanghai RAAS Hyperimmune Globulin Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Shanghai RAAS Hyperimmune Globulin Injection Product Portfolio
  18. 7.3.5 Shanghai RAAS Recent Developments
  19. 7.4 Hualan Bio
  20. 7.4.1 Hualan Bio Company Information
  21. 7.4.2 Hualan Bio Business Overview
  22. 7.4.3 Hualan Bio Hyperimmune Globulin Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Hualan Bio Hyperimmune Globulin Injection Product Portfolio
  24. 7.4.5 Hualan Bio Recent Developments
  25. 7.5 CBPO
  26. 7.5.1 CBPO Company Information
  27. 7.5.2 CBPO Business Overview
  28. 7.5.3 CBPO Hyperimmune Globulin Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 CBPO Hyperimmune Globulin Injection Product Portfolio
  30. 7.5.5 CBPO Recent Developments
  31. 7.6 Kedrion
  32. 7.6.1 Kedrion Company Information
  33. 7.6.2 Kedrion Business Overview
  34. 7.6.3 Kedrion Hyperimmune Globulin Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Kedrion Hyperimmune Globulin Injection Product Portfolio
  36. 7.6.5 Kedrion Recent Developments
  37. 7.7 Kamada
  38. 7.7.1 Kamada Company Information
  39. 7.7.2 Kamada Business Overview
  40. 7.7.3 Kamada Hyperimmune Globulin Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Kamada Hyperimmune Globulin Injection Product Portfolio
  42. 7.7.5 Kamada Recent Developments
  43. 7.8 Grifols
  44. 7.8.1 Grifols Company Information
  45. 7.8.2 Grifols Business Overview
  46. 7.8.3 Grifols Hyperimmune Globulin Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Grifols Hyperimmune Globulin Injection Product Portfolio
  48. 7.8.5 Grifols Recent Developments
  49. 7.9 Emergent
  50. 7.9.1 Emergent Company Information
  51. 7.9.2 Emergent Business Overview
  52. 7.9.3 Emergent Hyperimmune Globulin Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Emergent Hyperimmune Globulin Injection Product Portfolio
  54. 7.9.5 Emergent Recent Developments
  55. 7.10 CSL Behring
  56. 7.10.1 CSL Behring Company Information
  57. 7.10.2 CSL Behring Business Overview
  58. 7.10.3 CSL Behring Hyperimmune Globulin Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 CSL Behring Hyperimmune Globulin Injection Product Portfolio
  60. 7.10.5 CSL Behring Recent Developments
  61. 7.11 Biotest
  62. 7.11.1 Biotest Company Information
  63. 7.11.2 Biotest Business Overview
  64. 7.11.3 Biotest Hyperimmune Globulin Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Biotest Hyperimmune Globulin Injection Product Portfolio
  66. 7.11.5 Biotest Recent Developments
  67. 7.12 ADMA Biologics
  68. 7.12.1 ADMA Biologics Company Information
  69. 7.12.2 ADMA Biologics Business Overview
  70. 7.12.3 ADMA Biologics Hyperimmune Globulin Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 ADMA Biologics Hyperimmune Globulin Injection Product Portfolio
  72. 7.12.5 ADMA Biologics Recent Developments
8 North America
  1. 8.1 North America Hyperimmune Globulin Injection Market Size by Type
  2. 8.1.1 North America Hyperimmune Globulin Injection Revenue by Type (2021-2032)
  3. 8.1.2 North America Hyperimmune Globulin Injection Sales by Type (2021-2032)
  4. 8.1.3 North America Hyperimmune Globulin Injection Price by Type (2021-2032)
  5. 8.2 North America Hyperimmune Globulin Injection Market Size by Application
  6. 8.2.1 North America Hyperimmune Globulin Injection Revenue by Application (2021-2032)
  7. 8.2.2 North America Hyperimmune Globulin Injection Sales by Application (2021-2032)
  8. 8.2.3 North America Hyperimmune Globulin Injection Price by Application (2021-2032)
  9. 8.3 North America Hyperimmune Globulin Injection Market Size by Country
  10. 8.3.1 North America Hyperimmune Globulin Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Hyperimmune Globulin Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Hyperimmune Globulin Injection Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Hyperimmune Globulin Injection Market Size by Type
  2. 9.1.1 Europe Hyperimmune Globulin Injection Revenue by Type (2021-2032)
  3. 9.1.2 Europe Hyperimmune Globulin Injection Sales by Type (2021-2032)
  4. 9.1.3 Europe Hyperimmune Globulin Injection Price by Type (2021-2032)
  5. 9.2 Europe Hyperimmune Globulin Injection Market Size by Application
  6. 9.2.1 Europe Hyperimmune Globulin Injection Revenue by Application (2021-2032)
  7. 9.2.2 Europe Hyperimmune Globulin Injection Sales by Application (2021-2032)
  8. 9.2.3 Europe Hyperimmune Globulin Injection Price by Application (2021-2032)
  9. 9.3 Europe Hyperimmune Globulin Injection Market Size by Country
  10. 9.3.1 Europe Hyperimmune Globulin Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Hyperimmune Globulin Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Hyperimmune Globulin Injection Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Hyperimmune Globulin Injection Market Size by Type
  2. 10.1.1 China Hyperimmune Globulin Injection Revenue by Type (2021-2032)
  3. 10.1.2 China Hyperimmune Globulin Injection Sales by Type (2021-2032)
  4. 10.1.3 China Hyperimmune Globulin Injection Price by Type (2021-2032)
  5. 10.2 China Hyperimmune Globulin Injection Market Size by Application
  6. 10.2.1 China Hyperimmune Globulin Injection Revenue by Application (2021-2032)
  7. 10.2.2 China Hyperimmune Globulin Injection Sales by Application (2021-2032)
  8. 10.2.3 China Hyperimmune Globulin Injection Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Hyperimmune Globulin Injection Market Size by Type
  2. 11.1.1 Asia Hyperimmune Globulin Injection Revenue by Type (2021-2032)
  3. 11.1.2 Asia Hyperimmune Globulin Injection Sales by Type (2021-2032)
  4. 11.1.3 Asia Hyperimmune Globulin Injection Price by Type (2021-2032)
  5. 11.2 Asia Hyperimmune Globulin Injection Market Size by Application
  6. 11.2.1 Asia Hyperimmune Globulin Injection Revenue by Application (2021-2032)
  7. 11.2.2 Asia Hyperimmune Globulin Injection Sales by Application (2021-2032)
  8. 11.2.3 Asia Hyperimmune Globulin Injection Price by Application (2021-2032)
  9. 11.3 Asia Hyperimmune Globulin Injection Market Size by Country
  10. 11.3.1 Asia Hyperimmune Globulin Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Hyperimmune Globulin Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Hyperimmune Globulin Injection Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Hyperimmune Globulin Injection Market Size by Type
  2. 12.1.1 SAMEA Hyperimmune Globulin Injection Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Hyperimmune Globulin Injection Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Hyperimmune Globulin Injection Price by Type (2021-2032)
  5. 12.2 SAMEA Hyperimmune Globulin Injection Market Size by Application
  6. 12.2.1 SAMEA Hyperimmune Globulin Injection Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Hyperimmune Globulin Injection Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Hyperimmune Globulin Injection Price by Application (2021-2032)
  9. 12.3 SAMEA Hyperimmune Globulin Injection Market Size by Country
  10. 12.3.1 SAMEA Hyperimmune Globulin Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Hyperimmune Globulin Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Hyperimmune Globulin Injection Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Hyperimmune Globulin Injection Value Chain Analysis
  2. 13.1.1 Hyperimmune Globulin Injection Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Hyperimmune Globulin Injection Production Mode & Process
  6. 13.2 Hyperimmune Globulin Injection Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Hyperimmune Globulin Injection Distributors
  9. 13.2.3 Hyperimmune Globulin Injection Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst